Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens

Journal of Experimental Medicine

Volumn 203, Issue 3, 2006, Pages 777-788

  Suffia, Isabelle J ^a,b   Reckling, Stacie K ^b   Piccirillo, Ciriaco A ^c   Goldszmid, Romina S ^a   Belkaid, Yasmine ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ALLOGENEIC RESTRICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVITY; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGENS, PROTOZOAN; CELL LINE; CELL PROLIFERATION; CHRONIC DISEASE; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, KNOCKOUT; SPECIES SPECIFICITY; T-LYMPHOCYTES, REGULATORY;

EID: 33645077332     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20052056     Document Type: Article

References (41)

1. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol. 16:81-88.
2. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531-562.
3. Bluestone, J.A., and A.K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3:253-257.
4. Mills, K.H., and P. McGuirk. 2004. Antigen-specific regulatory T cells - their induction and role in infection. Semin. Immunol. 16:107-117.
5. + Tregs: limiting collateral damage. J. Clin. Invest. 114:1372-1378.
6. Fontenot, J.D., and A. Rudensky. 2005. A well adapted regulatory contrivance: the forkhead family transcription factor Foxp3 and regulatory T cell development. Nat. Immunol. 6:331-337.
7. Belkaid, Y., and B.T. Rouse. 2005. Natural regulatory T cells in infectious disease. Nat. Immunol. 6:353-360.
8. + regulatory T cells control Leishmania major persistence and immunity. Nature. 420:502-507.
9. Belkaid, Y., K.F. Hoffmann, S. Mendez, S. Kamhawi, M.C. Udey, T.A. Wynn, and D.L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194:1497-1506.
10. + regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J. Exp. Med. 200:201-210.
11. Wan, Y.Y., and R.A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA. 102:5126-5131.
12. von Stebut, E., Y. Belkaid, T. Jakob, D.L. Sacks, and M.C. Udey. 1998. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188:1547-1552.
13. + T cell receptors. Immunity. 21:267-277.
14. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197:403-411.
15. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor Foxp 3. Immunity. 22:329-341.
16. Hesse, M., C.A. Piccirillo, Y. Belkaid, J. Prufer, M. Mentink-Kane, M. Leusink, A.W. Cheever, E.M. Shevach, and T.A. Wynn. 2004. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 172:3157-3166.
17. + cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J. Immunol. 173:1224-1231.
18. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200:331-343.
19. + regulatory T cells which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood. 104:3249-3256.
20. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology. 40:1062-1071.
21. MacDonald, A.J., M. Duffy, M.T. Brady, S. McKiernan, W. Hall, J. Hegarty, M. Curry, and K.H. Mills. 2002. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 185:720-727.
22. + regulatory T cells in vivo. J. Exp. Med. 198:249-258.
23. Klein, L., K. Khazaie, and H. von Boehmer. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA. 100:8886-8891.
24. Andersson, J., A. Boasso, J. Nilsson, R. Zhang, N.J. Shire, S. Lindback, G.M. Shearer, and C.A. Chougnet. 2005. The prevalence of regulatory T cells in Lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 174:3143-3147.
25. Pawelec, G., Q. Ouyang, G. Colonna-Romano, G. Candore, D. Lio, and C. Caruso. 2002. Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. Trends Immunol. 23:330-332.
26. Tang, Q., K.J. Henriksen, M. Bi, E.B. Finger, G. Szot, J. Ye, E.L. Masteller, H. McDevitt, M. Bonyhadi, and J.A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199:1455-1465.
27. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198:235-247.
28. Sugimoto, K., F. Ikeda, J. Stadanlick, F.A. Nunes, H.J. Alter, and K.M. Chang. 2003. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology. 38:1437-1448.
29. Oswald-Richter, K., S.M. Grill, N. Shariat, M. Leelawong, M.S. Sundrud, D.W. Haas, and D. Unutmaz. 2004. HIV Infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2:E198.
30. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78:2454-2459.
31. + T cells on Plasmodium berghei NK65 infection in BALB/c mice. Int. J. Parasitol. 33:175-183.
32. + regulatory T cells. Nat. Med. 10:29-30.
33. + regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood. 103:3428-3430.
34. + T cell responses. J. Exp. Med. 198:889-901.
35. + regulatory T cells. J. Immunol. 170:3939-3943.
36. Singh, K.P., H.C. Gerard, A.P. Hudson, T.R. Reddy, and D.L. Boros. 2005. Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice. Immunology. 114:410-417.
37. Spath, G.F., and S.M. Beverley. 2001. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp. Parasitol. 99:97-103.
38. Belkaid, Y., B. Butcher, and D.L. Sacks. 1998. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur. J. Immunol. 28:1389-1400.
39. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149:175-180.
40. Lutz, M.B., N. Kukutsch, A.L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:77-92.
41. O'Farrell, A.M., Y. Liu, K.W. Moore, and A.L. Mui. 1998. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J. 17:1006-1018.